γδ T cells mediate post-stroke immunoinflammation through the TLR4/IL-17 axis, with their synergy with αβ T cells and interspecies heterogeneity presenting both therapeutic opportunities and challenges. The gene discussed is TLR4; the disease is stroke disorder.